Skip to main content
PMC home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1997;75(1):69–80.

Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.

S E Robertson 1, F T Cutts 1, R Samuel 1, J L Diaz-Ortega 1
PMCID: PMC2486979  PMID: 9141752

Abstract

In 1995-96 we conducted a review of rubella immunization strategies. Worldwide, 78 countries (more than one-third) reported a national policy of using rubella vaccine. This was closely related to country economic status. Based on the United Nations country classification, rubella vaccine is used in 92% of industrialized countries, 36% of those with economies-in-transition, and 28% of developing countries. Cases of congenital rubella syndrome (CRS) may be prevented as follows: by providing direct protection to women and/or schoolgirls (a selective vaccination strategy); by vaccinating boys and girls to provide indirect protection by reducing the transmission of rubella virus (a childhood vaccination strategy); or by a combination of these approaches (a combined strategy). A combined strategy was most commonly reported (60% of countries); seven countries (9%) reported a selective strategy; and 24 countries (31%) reported only childhood immunization. Experience has shown that it is essential to include vaccination of women of childbearing age in any rubella control strategy. Childhood vaccination alone may pose a risk of an increase in CRS cases. Although many countries have introduced rubella vaccine, few report any data on the impact of vaccination. Countries using rubella vaccine need to establish surveillance for rubella and CRS and monitor coverage in each of the target groups.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson R. M., May R. M. Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg (Lond) 1983 Apr;90(2):259–325. doi: 10.1017/s002217240002893x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baba K., Yabuuchi H., Okuni H., Harima R., Minekawa Y., Taniuchi M., Otsuka T., Takahashi M., Okuno Y. Rubella epidemic in an institution: protective value of live rubella vaccine and serological behavior of vaccinated, revaccinated and naturally immune groups. Biken J. 1978 Mar;21(1):25–31. [PubMed] [Google Scholar]
  3. Bakasun V., Suzanić-Karnincić J. A rubella outbreak in the region of Rijeka, Croatia. Int J Epidemiol. 1995 Apr;24(2):453–456. doi: 10.1093/ije/24.2.453. [DOI] [PubMed] [Google Scholar]
  4. Balfour H. H., Jr, Groth K. E., Edelman C. K., Amren D. P., Best J. M., Banatvala J. E. Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet. 1981 May 16;1(8229):1078–1080. doi: 10.1016/s0140-6736(81)92243-1. [DOI] [PubMed] [Google Scholar]
  5. Baxter D. N. Control of the congenital rubella syndrome in Jamaica. West Indian Med J. 1986 Mar;35(1):50–54. [PubMed] [Google Scholar]
  6. Berger S. A., Ginsberg G. M., Slater P. E. Cost-benefit analysis of routine mumps and rubella vaccination for Israeli infants. Isr J Med Sci. 1990 Feb;26(2):74–80. [PubMed] [Google Scholar]
  7. Best J. M. Rubella vaccines: past, present and future. Epidemiol Infect. 1991 Aug;107(1):17–30. doi: 10.1017/s0950268800048640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Boué A., Nicolas A., Montagnon B. Reinfection with rubella in pregnant women. Lancet. 1971 Jun 19;1(7712):1251–1253. doi: 10.1016/s0140-6736(71)91775-2. [DOI] [PubMed] [Google Scholar]
  9. Brand N., Legum S., Saunders J., Fogel A. Congenital rubella in Israel following the 1978-79 rubella epidemic. Isr J Med Sci. 1983 Oct;19(10):925–928. [PubMed] [Google Scholar]
  10. Chang T. W., DesRosiers S., Weinstein L. Clinical and serologic studies of an outbreak of rubella in a vaccinated population. N Engl J Med. 1970 Jul 30;283(5):246–248. doi: 10.1056/NEJM197007302830507. [DOI] [PubMed] [Google Scholar]
  11. Cochi S. L., Edmonds L. E., Dyer K., Greaves W. L., Marks J. S., Rovira E. Z., Preblud S. R., Orenstein W. A. Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination. Am J Epidemiol. 1989 Feb;129(2):349–361. doi: 10.1093/oxfordjournals.aje.a115138. [DOI] [PubMed] [Google Scholar]
  12. Cradock-Watson J. E. Laboratory diagnosis of rubella: past, present and future. Epidemiol Infect. 1991 Aug;107(1):1–15. doi: 10.1017/s0950268800048639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cutts F. T., Robertson S. E., Diaz-Ortega J. L., Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS. Bull World Health Organ. 1997;75(1):55–68. [PMC free article] [PubMed] [Google Scholar]
  14. Danon Y. L., Adir Y., Abend I., Zaaide Y., Green M. S. Prevalence of antibodies against measles, mumps and rubella in Israeli young adults. Isr J Med Sci. 1992 Oct;28(10):733–736. [PubMed] [Google Scholar]
  15. De Azevedo Neto R. S., Silveira A. S., Nokes D. J., Yang H. M., Passos S. D., Cardoso M. R., Massad E. Rubella seroepidemiology in a non-immunized population of São Paulo State, Brazil. Epidemiol Infect. 1994 Aug;113(1):161–173. doi: 10.1017/s095026880005158x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. De Spiegelaere M., Dramaix M., Hennart P. Inégalités sociales et prévention: le statut vaccinal des adolescents. Rev Epidemiol Sante Publique. 1996 Jun;44(3):228–236. [PubMed] [Google Scholar]
  17. Fogel A., Gerichter C. B., Handsher R., Bernholtz-Barnea B. The impact of rubella epidemics on pregnant women, proof for the necessity of pre-marital screening and vaccination. Dev Biol Stand. 1979;43:349–353. [PubMed] [Google Scholar]
  18. Frey T. Report of an international meeting on rubella vaccines and vaccination, 9 August 1993, Glasgow, United Kingdom. J Infect Dis. 1994 Sep;170(3):507–509. doi: 10.1093/infdis/170.3.507. [DOI] [PubMed] [Google Scholar]
  19. Horstmann D. M., Liebhaber H., Le Bouvier G. L., Rosenberg D. A., Halstead S. B. Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic. N Engl J Med. 1970 Oct 8;283(15):771–778. doi: 10.1056/NEJM197010082831501. [DOI] [PubMed] [Google Scholar]
  20. Howson C. P., Fineberg H. V. The ricochet of magic bullets: summary of the Institute of Medicine Report, Adverse Effects of Pertussis and Rubella Vaccines. Pediatrics. 1992 Feb;89(2):318–324. [PubMed] [Google Scholar]
  21. Isacsohn M., Nishmi M., Swartz T. A. Rubella in Jerusalem. 2. Clinical and serologic findings in children with congenital rubella. Isr J Med Sci. 1979 Jan;15(1):17–22. [PubMed] [Google Scholar]
  22. Isacsohn M., Rudensky B., Eidelman A. I., Paz E., Weintraub G., Nubani N., Swartz T. A. Surveillance of congenital rubella and the immunity status to rubella in the Jerusalem area. Isr J Med Sci. 1983 Oct;19(10):929–933. [PubMed] [Google Scholar]
  23. Lerman S. J., Bollinger M., Brunken J. M. Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27/3) virus vaccines, singly and in combination. Pediatrics. 1981 Jul;68(1):18–22. [PubMed] [Google Scholar]
  24. Lindegren M. L., Fehrs L. J., Hadler S. C., Hinman A. R. Update: rubella and congenital rubella syndrome, 1980-1990. Epidemiol Rev. 1991;13:341–348. doi: 10.1093/oxfordjournals.epirev.a036077. [DOI] [PubMed] [Google Scholar]
  25. Massad E., Azevedo-Neto R. S., Burattini M. N., Zanetta D. M., Coutinho F. A., Yang H. M., Moraes J. C., Pannuti C. S., Souza V. A., Silveira A. S. Assessing the efficacy of a mixed vaccination strategy against rubella in São Paulo, Brazil. Int J Epidemiol. 1995 Aug;24(4):842–850. doi: 10.1093/ije/24.4.842. [DOI] [PubMed] [Google Scholar]
  26. Miller C. L., Miller E., Waight P. A. Rubella susceptibility and the continuing risk of infection in pregnancy. Br Med J (Clin Res Ed) 1987 May 16;294(6582):1277–1278. doi: 10.1136/bmj.294.6582.1277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Morgan-Capner P., Hodgson J., Hambling M. H., Dulake C., Coleman T. J., Boswell P. A., Watkins R. P., Booth J., Stern H., Best J. M. Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet. 1985 Feb 2;1(8423):244–246. doi: 10.1016/s0140-6736(85)91027-x. [DOI] [PubMed] [Google Scholar]
  28. Morgan-Capner P., Wright J., Miller C. L., Miller E. Surveillance of antibody to measles, mumps, and rubella by age. BMJ. 1988 Sep 24;297(6651):770–772. doi: 10.1136/bmj.297.6651.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. O'Shea S., Best J. M., Banatvala J. E., Marshall W. C., Dudgeon J. A. Persistence of rubella antibody 8-18 years after vaccination. Br Med J (Clin Res Ed) 1984 Apr 7;288(6423):1043–1043. doi: 10.1136/bmj.288.6423.1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Orenstein W. A., Bart K. J., Hinman A. R., Preblud S. R., Greaves W. L., Doster S. W., Stetler H. C., Sirotkin B. The opportunity and obligation to eliminate rubella from the United States. JAMA. 1984 Apr 20;251(15):1988–1994. [PubMed] [Google Scholar]
  31. Peckham C. S., Marshall W. C., Dudgeon J. A. Rubella vaccination of schoolgirls: factors affecting vaccine uptake. Br Med J. 1977 Mar 19;1(6063):760–761. doi: 10.1136/bmj.1.6063.760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Prabhakar P., Bailey A., Smikle M. F., McCaw-Binns A., Ashley D. Seroprevalence of toxoplasma gondii, rubella virus, cytomegalovirus herpes simplex virus (TORCH) and syphilis in Jamaican pregnant women. West Indian Med J. 1991 Dec;40(4):166–169. [PubMed] [Google Scholar]
  33. Robertson C. M., Bennett V. J., Jefferson N., Mayon-White R. T. Serological evaluation of a measles, mumps, and rubella vaccine. Arch Dis Child. 1988 Jun;63(6):612–616. doi: 10.1136/adc.63.6.612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Robertson S. E., Cochi S. L., Bunn G. A., Morse D. L., Preblud S. R. Preventing rubella: assessing missed opportunities for immunization. Am J Public Health. 1987 Oct;77(10):1347–1349. doi: 10.2105/ajph.77.10.1347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Rudnicka H. Rózyczka w 1992 roku. Przegl Epidemiol. 1994;48(1-2):75–78. [PubMed] [Google Scholar]
  36. Sabin A. B. Perspectives on current use of some virus vaccines in the USA. Measles, rubella, poliomyelitis, and influenza in the USA: contrasts in control by vaccination. Pediatr Res. 1979 May;13(5 Pt 2):674–683. doi: 10.1203/00006450-197905001-00004. [DOI] [PubMed] [Google Scholar]
  37. Schoub B. D., Johnson S., McAnerney J. M., Wagstaff L. A., Matsie W., Reinach S. G., Vandevoorde D., Andre F. E., Teuwen D. E. Measles, mumps and rubella immunization at nine months in a developing country. Pediatr Infect Dis J. 1990 Apr;9(4):263–267. doi: 10.1097/00006454-199004000-00008. [DOI] [PubMed] [Google Scholar]
  38. Singh R., John T. J., Cherian T., Raghupathy P. Immune response to measles, mumps & rubella vaccine at 9, 12 & 15 months of age. Indian J Med Res. 1994 Oct;100:155–159. [PubMed] [Google Scholar]
  39. Slater P. E., Ben-Zvi T., Fogel A., Ehrenfeld M., Ever-Hadani S. Absence of an association between rubella vaccination and arthritis in underimmune postpartum women. Vaccine. 1995 Nov;13(16):1529–1532. doi: 10.1016/0264-410x(95)00096-j. [DOI] [PubMed] [Google Scholar]
  40. Stevenson J., O'Brien S., Christie P., Cowden J. Resurgence of rubella. Lancet. 1996 Apr 6;347(9006):980–981. doi: 10.1016/s0140-6736(96)91474-9. [DOI] [PubMed] [Google Scholar]
  41. Swartz T. A., Hornstein L., Epstein I. Epidemiology of rubella and congenital rubella infection in Israel, a country with a selective immunization program. Rev Infect Dis. 1985 Mar-Apr;7 (Suppl 1):S42–S46. doi: 10.1093/clinids/7.supplement_1.s42. [DOI] [PubMed] [Google Scholar]
  42. Weibel R. E., Villarejos V. M., Klein E. B., Buynak E. B., McLean A. A., Hilleman M. R. Clinical and laboratory studies of live attenuated RA 27/3 and HPV 77-DE rubella virus vaccines. Proc Soc Exp Biol Med. 1980 Oct;165(1):44–49. doi: 10.3181/00379727-165-40931. [DOI] [PubMed] [Google Scholar]
  43. de Quadros C. A., Olivé J. M., Hersh B. S., Strassburg M. A., Henderson D. A., Brandling-Bennett D., Alleyne G. A. Measles elimination in the Americas. Evolving strategies. JAMA. 1996 Jan 17;275(3):224–229. doi: 10.1001/jama.275.3.224. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES